Alberto Corona
About Me
Alberto Corona is a postdoctoral fellow in the Kenny lab in the neuroscience department at the Icahn School of Medicine at Mount Sinai. Alberto earned his neuroscience PhD in 2022 in the lab of Dr. Stephen Shea at Cold Spring Harbor Laboratory and his B.S. in Biology at the University of California, Riverside in 2016.
Language
Position
Research Topics
Addiction, Neurobiology, Neuromodulation, Neuroscience, Systems Neuroscience
Download the CV
About Me
Alberto Corona is a postdoctoral fellow in the Kenny lab in the neuroscience department at the Icahn School of Medicine at Mount Sinai. Alberto earned his neuroscience PhD in 2022 in the lab of Dr. Stephen Shea at Cold Spring Harbor Laboratory and his B.S. in Biology at the University of California, Riverside in 2016.
Language
Position
Research Topics
Addiction, Neurobiology, Neuromodulation, Neuroscience, Systems Neuroscience
Download the CVEducation
AS, San Bernardino Valley College
BS, University of California, Riverside
PhD, Cold Spring Harbor Laboratory
, Icahn School of Medicine at Mount Sinai
Awards
2015
HHMI EXROP Fellowship
Howard Hughes Medical Institute
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. CORONA has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. CORONA has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.